The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Linking β-Catenin to Androgen-signaling Pathway
Open accessAbstract
The androgen-signaling pathway is important for the growth and progression of prostate cancer cells. The growth-promoting effects of androgen on prostate cells are mediated mostly through the androgen receptor (AR). There is increasing evidence that transcription activation by AR is mediated through interaction with other cofactors. beta-Catenin plays a critical role in embryonic development and tumorigenesis through its effects on E-cadherin-mediated cell adhesion and Wnt-dependent signal transduction. Here, we demonstrate that a specific protein-protein interaction occurs between beta-catenin and AR. Unlike the steroid hormone receptor coactivator 1 (SRC1), beta-catenin showed a strong interaction with AR but not with other steroid hormone receptors such as estrogen receptor alpha, progesterone receptor beta, and glucocorticoid receptor. The ligand binding domain of AR and the NH(2) terminus combined with the first six armadillo repeats of beta-catenin were shown to be necessary for the interaction. Through this specific interaction, beta-catenin augments the ligand-dependent activity of AR in prostate cancer cells. Moreover, expression of E-cadherin in E-cadherin-negative prostate cancer cells results in redistribution of the cytoplasmic beta-catenin to the cell membrane and reduction of AR-mediated transcription. These data suggest that loss of E-cadherin can elevate the cellular levels of beta-catenin in prostate cancer cells, which may directly contribute to invasiveness and a more malignant tumor phenotype by augmenting AR activity during prostate cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“While FKBP52 is known to functionally interact with AR, GR and PR [6–8], β-catenin only interacts strongly with AR, but not GR and PR [20].”
From The FKBP52 Cochaperone Acts in Synergy with β-Catenin to Potentiate Androgen Receptor Signaling (2015) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Polakis, P. (2000) · Genes & Development · doi:10.1101/gad.14.15.1837 · Cited by 3,183
Landis, S., Murray, T., Bolden, S., & Wingo, P. A. (1999) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.1.8 · Cited by 3,068
Functional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
Genomic Libraries and a Host Strain Designed for Highly Efficient Two-Hybrid Selection in Yeast
James, P. M., Halladay, J. T., & Craig, E. A. (1996) · Genetics · doi:10.1093/genetics/144.4.1425 · Cited by 2,638
β‐catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,586
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
Oñate, S. A., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (1995) · Science · doi:10.1126/science.270.5240.1354 · Cited by 2,398
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos
Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destrée, O., & Clevers, H. (1996) · Cell · doi:10.1016/s0092-8674(00)80112-9 · Cited by 1,824
Flagged first, then by citations
Research works printed but not linked: 12
- Jenster, 1999, Semin. Oncol., 26, 407
- Gayther, 1998, Cancer Res., 58, 4086
- Richmond, 1997, Cancer Res., 57, 3189
- Sasaki, 2000, Cancer Res., 60, 7057
- Truica, 2000, Cancer Res., 60, 4709
- Shibata, 1997, Recent Prog. Horm. Res., 52, 141
- Pang, 1997, Cancer Res., 57, 495
- Birchmeier, 1995, Cancer Surv., 24, 129
- Umbas, 1992, Cancer Res., 52, 5104
- Graff, 1995, Cancer Res., 55, 5195
- Voeller, 1998, Cancer Res., 58, 2520
- van de Wetering, 2001, Cancer Res., 61, 278
Cited by
Sorted by citations
Items 301–342 of 342
Somatic Molecular Genetics of Prostate Cancer
Humbert, L., & Chevrette, M. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0449-2_5 · Cited by 2
Die Rolle des Androgenrezeptors im hormonrefraktären Prostatakarzinom
Rinnab, L. J., Hessenauer, A., Schütz, S., Schmid, E., Küfer, R., Finter, F., Hautmann, R. E., Spindler, K., & Cronauer, M. V. (2008) · Der Urologe · doi:10.1007/s00120-008-1637-1 · Cited by 1
The role of growth factor-induced changes in cell fate in prostate cancer progression
Yu, M., Smolen, G. A., Haber, D. A., & Maheswaran, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979811.024 · Cited by 1
The Androgen Receptor in Breast Cancer: Biology and Treatment Considerations
Gucalp, A., & Traina, T. A. (2011) · Current Breast Cancer Reports · doi:10.1007/s12609-011-0059-z · Cited by 1
Kilbourne, E. J., Kenney, T. F., Chippari, S. M., McNally, C., Wang, Y., Lam, H., Vishwanathan, K., Nagpal, S., Thompson, C. C., & Chekler, E. L. P. (2013) · MedChemComm · doi:10.1039/c3md20341g · Cited by 1
Relation of the Wnt/β-catenin signaling pathway with gynecological cancers
Tanir, H. G., Demirezen, Ş., & Beksaç, M. S. (2010) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-0904-24 · Cited by 1
Prostate Molecular Oncogenesis
Gelmann, E. P. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-079-3_4 · Cited by 1
Pucci‐Minafra, I. (2014) · Springer eBooks · doi:10.1007/978-81-322-0843-3_9 · Cited by 1
Tanner, M. J., Levina, E. M., Shtutman, M. S., Chen, M., Ohouo, P. Y., & Buttyan, R. (2009) · Springer eBooks · doi:10.1007/978-0-387-69179-4_24 · Cited by 1
Molecular and prognostic markers in prostate cancer
HALVORSEN, O. J. (2008) · Apmis · doi:10.1111/j.1600-0463.2008.0s123.x · Cited by 1
THE ROLE OF LIGAND IN THE INTERACTION OF ANDROGEN RECEPTOR WITH DNA AND COACTIVATORS
Karvonen, U. (2003) · Työväentutkimus Vuosikirja · Cited by 1
Prostate Cancer Progression to Androgen Independent Disease: The Role of the Wnt/β-Catenin Pathway
Jacqueline, R., Huang, Y., & Pers, S. (2011) · InTech eBooks · doi:10.5772/26201
Prostate Cancer Progression to Androgen Independent Disease: The Role of the PI3K/AKT Pathway
Jacqueline, R., Huang, Y., Persad, A. R. L., & Pers, S. (2013) · InTech eBooks · doi:10.5772/53483
Invasive and Metastatic Properties of Advanced Prostate Cancer
Jennbacken, K. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University)
PTEN Regulates Beta-Catenin in Androgen Signaling: Implication in Prostate Cancer Progression
Sun, Z. (2004) · doi:10.21236/ada425958
Self-citationAndrogen Action, Wnt Signaling, and Prostate Tumorigenesis
Sun, Z., & Lee, S. H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6182-1_7
Self-citationPotential Role of Androgens and Androgen Receptors in Alzheimer's Disease
Raber, J. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-661-4_30 · Cited by 3
Cancer Stem Cells in Prostate Cancer
Kroon, P., Pellacani, D., Frame, F. M., Maitland, N. J., & Collins, A. T. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-246-5_6
Review Article ANDROGEN RECEPTORS IN PROSTATE CANCER
Čulig, Z., Klocker, H., Bartsch, G. H., Steiner, H., & Hobisch, A. (2003)
Effect of an LH-RH analogue on adhesion molecules in human prostate cancer cells
Angelucci, D., Iacopino, F., & Sica, G. (2007) · Urologia Journal · doi:10.5301/ru.2010.5866
Dissecting the prostate cancer stem cell niche inside the bone marrow
Tang, K. D. (2015)
Current state of the evolving MMMN cancer progression models of cancer
Thiagalingam, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979811.022
Causes and consequences of genomic instability in prostatic carcinogenesis.
Joshua, A. M. (2009) · TSpace (University of Toronto)
Modulation of Wnt/β-Catenin Signaling by Chemoprevention
Rashid, S. (2017) · Springer eBooks · doi:10.1007/978-981-10-2579-2_13
Investigating the Role of the Epithelial-Mesenchymal Plasticity in Prostate Cancer
Stylianou, N. (2017) · Queensland University of Technology · doi:10.5204/thesis.eprints.107979
β-Catenin, its Binding Partners and Signalling Mechanisms: Implications in Prostate Cancer
Davies, G., Harrison, G. M., & Mason, M. D. (2007) · Springer eBooks · doi:10.1007/978-1-4020-5847-9_9
Modulation of androgen receptor action by the cochaperone BAG-1L
Shatkina, L. (2003) · PubMed · doi:10.5445/ir/3462003
WARDLE, E. N. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-538-5_18
Glutamine synthetase as a target of β-catenin: new insights into hepatic heterogeneity
Gebhardt, R., Ueberham, E., & Gaunitz, F. (2007) · Springer eBooks · doi:10.1007/1-4020-4456-9_30
Effect of an LH-RH analogue on adhesion molecules in human prostate cancer cells
Angelucci, C., Iacopino, F., & Sica, G. (2007) · Urologia Journal · doi:10.1177/039156030707400205
Androgen Signaling in Metastatic Bone Disease
Arumugam, D., Izadmehr, S., & Levine, A. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11249-8
Androgen Receptor Signaling: A Central and Evolving Theme in Prostate Cancer Treatment
Banerjee, P. P., & Srivastava, S. K. (2023) · Springer eBooks · doi:10.1007/978-981-99-2196-6_24-1
Androgen Receptor Signaling: A Central and Evolving Theme in Prostate Cancer Treatment
Banerjee, P. P., & Srivastava, S. K. (2024) · Springer eBooks · doi:10.1007/978-981-99-6263-1_24 · Cited by 1
Feshangchian-Atashbar, S., Ghamari, A., Jafarnejad-Komachali, S., Azhdari, M., & Shoae‐Hassani, A. (2025) · Research Square · doi:10.21203/rs.3.rs-6905198/v1
Somatic Genetic Changes in Prostate Cancer
Helenius, M. A., Waltering, K. K., & Visakorpi, T. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-079-3_5
ADT and activation of HGF and WNT axes in double-null prostate cancer
Leung, D. H. L., Adzavon, Y. M., Chu, G., Park, T. J., Nikias, K., Kim, C.-W., Liu, C., & Sun, Z. (2026) · Nature Reviews Urology · doi:10.1038/s41585-026-01129-8
Self-citationKouspou, M., Zhu, A., Martires, L. C. M., Tewari, A. K., Mehrazin, R., & Kyprianou, N. (2026) · Endocrinology · doi:10.1210/endocr/bqag046
Metadata
- Authors
- Yang, F., Li, X., Sharma, M., Sasaki, C. Y., Longo, D. L., Lim, B., & Sun, Z.
- Affiliations
- Stanford Medicine (US)
- Beth Israel Deaconess Medical Center (US)
- National Institutes of Health (US)
- Corresponding author
- Sun, Zijie
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 277
- Issue
- 13
- Pages
- 11336-11344
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2022810442
- Cited by
- 342
- References
- 54
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 6 · 2021: 4 · 2020: 10 · 2019: 14 · 2018: 10 · 2017: 19 · 2016: 7 · 2015: 17 · 2014: 12 · 2013: 19 · 2012: 10
- FWCI
- 20.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r01dk054417-01)
- National Cancer Institute (CA-70297, R01CA087767, R29CA070297, R01CA070297)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK061002, DK54417, R56DK061002, R01DK047636, DK47636)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- β-catenin, androgen receptor, androgen signaling, prostate cancer, protein-protein interaction, E-cadherin, Wnt signaling, armadillo repeats, transcriptional coactivation, steroid hormone receptors, tumor progression, cell adhesion
- MeSH terms
- Androgens, Cytoskeletal Proteins, Humans, Ligands, Male, Prostatic Neoplasms, Receptors, Androgen, Tumor Cells, Cultured, Signal Transduction, Trans-Activators, Two-Hybrid System Techniques, beta Catenin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
